Our Recommendations
- Global report on hypertension: the race against a silent killer (2023)
- Diretriz para o tratamento farmacológico da hipertensão arterial em adultos (2021)
- مبادئ توجيهيّة بشأن العلاج الدوائي لفرط ضغط الدم لدى البالغين (2021)
- Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk (2007)
- Guideline for the pharmacological treatment of hypertension in adults (2021)
New Publications
- South African cardiovascular risk stratification guideline for non-cardiac surgery (2021)
- Guidelines for Management of ST-Elevated Myocardial Infarction (2022)
- National User Guide on the Prevention and Treatment of Hypertension in Adults at the PHC Level 2021 (2021)
- Guideline for the pharmacological treatment of hypertension in adults (2021)
- 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas (2022)
Filter
53
Featured
Recommendations
7
New Publications
16
Language
Document type
No document type
26
Guidelines
11
Fact sheets
5
Manuals
4
Studies & Reports
4
Infographics
2
Strategic & Response Plan
1
Countries / Regions
Latin America and the Carribbean
5
Global
1
West and Central Africa
1
Middle East and North Africa
1
East and Southern Africa
1
South Africa
1
Brazil
1
Ecuador
1
India
1
Bahamas
1
Authors & Publishers
Publication Years
Category
Toolboxes
Clinical Aspects & Diagnosis
9
Clinical Guidelines
5
Prevention & Strategies
3
Studies & Reports
3
Stroke
2
Online Courses
1
Internet Resources
1
Capacity Building & Resources
1
Neurological Disorders
1
Los módulos que conforman el paquete técnico HEARTS están dirigidos a los formuladores de políticas públicas y gerentes, directores o coordinadores de programas a diferentes niveles dentro de los ministerios de salud cuyo trabajo influye sobre la prestación de servicios de salud a nivel primar...
Los módulos que conforman el paquete técnico HEARTS están dirigidos a los formuladores de políticas públicas y gerentes, directores o coordinadores de programas a diferentes niveles dentro de los ministerios de salud cuyo trabajo influye sobre la prestación de servicios de salud a nivel primar...
This Cardiac Rehabilitation Change Package was completed by the Centers for Disease Control and Prevention (CDC) in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) with the purpose of helping cardiac rehabilitation programs, hospital quality improv...
This volume on CVDs, renal, and respiratory disorders has particularly high value. It carries the potential to become the most effective game-changer in global health by helping all countries to combat, contain, and control the biggest killer presently prowling the globe and by enabling us to reach ...
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modul...
Global Heart, March 2014, Vol. 9 No.1
Sub-Saharan Africa has the world’s youngest populations. The pattern of cardiovascular disease (CVD) is distinctly different from other regions, with a lower proportion of causes stemming from atherosclerosis, and a younger average age at CVD death. Sub-Sahar...
Global Hear, March 2014, Vol. 9 no.1
Lancet 2012; 380: 611–19
Series: Hypertension 3
Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk
recommended
These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people
